c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Faeth Therapeutics (FTH) Reports 33% Response Rate in Endometrial Cancer Study
GuruFocus | Nov 9, 2026 1:50 PM EST
Related Stocks: FTH ,
Read original article